SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-060718
Filing Date
2024-03-06
Accepted
2024-03-06 16:11:41
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d778597ds3.htm S-3 285006
2 EX-4.4 d778597dex44.htm EX-4.4 282550
3 EX-4.5 d778597dex45.htm EX-4.5 275081
4 EX-5.1 d778597dex51.htm EX-5.1 16971
5 EX-23.1 d778597dex231.htm EX-23.1 1889
6 EX-FILING FEES d778597dexfilingfees.htm EX-FILING FEES 57139
7 GRAPHIC g778597g01a01.jpg GRAPHIC 83286
8 GRAPHIC g778597g0305204728318.jpg GRAPHIC 2803
  Complete submission text file 0001193125-24-060718.txt   1038536
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277699 | Film No.: 24725978
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)